Marcin Frąckiewicz

{“@context”:”https://schema.org”,”@type”:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-17-10-2025/#live”,”headline”:”Stock Market Today 17.10.2025″,”description”:”Live rolling coverage of stock markets, macro data, and major moves.”,”datePublished”:”2025-10-17T06:01:01-04:00″,”dateModified”:”2025-10-19T06:00:10-04:00″,”coverageStartTime”:”2025-10-17T06:01:01-04:00″,”coverageEndTime”:”2025-10-19T06:00:10-04:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-17-10-2025/#live/u/554ef6f94eda71f5″,”headline”:”IndiGo Finalizes 30-Airbus A350 Order, Lifting Total A350 Commitments to 60″,”articleBody”:”IndiGo has firmed up a commitment for 30 Airbus A350s, converting a June MoU into a binding order and lifting its total A350 orders to 60. The deal underscores growing demand for widebodies as the carrier expands long-haul capacity. Airbus notes the A350 already supports up to 50% SAF use and aims to make all aircraft 100% SAF-capable by 2030. Globally, the A350 program has logged over 1,400 orders from 63 customers through September 2025, highlighting the

Record Stock Surge on Phase 3 Breakthrough Praxis Precision Medicines shares skyrocketed on October 16, 2025, after the biotech reported game-changing Phase 3 trial results for its essential tremor drug. The stock closed that Thursday at $162.71, up over 183% in a single daymedcitynews.com. Earlier that morning, Praxis announced that ulixacaltamide – its experimental therapy for essential tremor – had succeeded in two pivotal late-stage studies. The news sent PRAX stock soaring more than threefold before the opening bellreuters.comreuters.com, smashing its previous highs. By midday, Reuters estimated Praxis was on track to add about $2.67 billion to its market capitalization if gains

Stock Price Stumbles as Market Volatility Bites KKR’s stock has been on a bumpy ride in recent weeks. On October 16, the private equity giant’s shares plunged nearly 7% intraday, closing around $116reuters.com. That marks a sharp one-day drop amid broader market volatility, as investors have been rotating out of higher-valuation financial stocks in the face of rising interest rates. The latest slide extends a downward trend: KKR is now down about 14% year-to-datets2.tech and roughly 16% lower over the past monthsimplywall.st. By comparison, the S&P 500 is up modestly YTD, and even the financial sector index is up around

Toronto, Ontario – October 16, 2025: Denison Mines Corp. (NYSE American: DNN) is riding a wave of uranium market optimism, with its stock surging to multi-year highs this week. The Canadian uranium developer’s shares have spiked amid soaring uranium prices and a string of positive company milestones. Investors are abuzz over Denison’s progress on key projects and what it means for the future of nuclear energy. Below are the key takeaways from the latest developments: DNN Stock Rockets on Uranium Optimism Denison Mines’ U.S.-listed shares have been on a tear in October. The stock is up roughly 15% in the

Sources: Company filings and press releasesmarkets.businessinsider.com; financial news (Reuters, LA Times, AP, MorningAgClips)reuters.comlatimes.commorningagclips.com; TS2.tech analysists2.techts2.techts2.tech; market data (MarketBeat, Investing.com)ts2.techts2.tech; industry reports (Good Food Institute, FoodNavigator)latimes.comts2.tech.